Minerva Neurosciences Reports Second Quarter 2020 Financial Results and Business Updates
August 03, 2020 07:30 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central...